Chronic Low MCHC: Clinical Significance and Management

Primary Diagnostic Consideration

The American Gastroenterological Association suggests that iron deficiency anemia is the most important cause of chronically low MCHC and requires comprehensive gastrointestinal evaluation to exclude malignancy 1
In adult men and post-menopausal women, gastrointestinal blood loss is the predominant cause, making exclusion of colonic and gastric carcinoma the prime concern 2
Pre-menopausal women most commonly have menstrual blood loss as the etiology 2
Low MCHC specifically reflects hypochromic cells resulting from severe iron restriction during red blood cell production 1

The minimum evaluation must include complete blood count with RBC indices, serum ferritin, and C-reactive protein, as recommended by the American College of Physicians 1

Serum ferritin <12 μg/dL is diagnostic of iron deficiency, according to the World Health Organization 2
Ferritin may be falsely elevated (>12-15 μg/dL) in concurrent inflammation, malignancy, or hepatic disease, though values >100 μg/dL essentially exclude iron deficiency 2
Transferrin saturation <30% supports the diagnosis, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 2
Mean corpuscular volume serves as a late marker of iron deficiency, as indicated by the Kidney Disease: Improving Global Outcomes guidelines 3

All adult men and post-menopausal women with iron deficiency require both upper gastrointestinal endoscopy (including small bowel biopsy) and colonoscopy or barium enema to exclude malignancy, as recommended by the American College of Gastroenterology 2
This applies even in the absence of overt blood loss or obvious cause 2
Further gastrointestinal investigation is warranted only in transfusion-dependent anemia or visible blood loss 2
In non-dialysis CKD patients without erythropoietic-stimulating agents or known iron losses, iron deficiency should prompt careful assessment for gastrointestinal bleeding, according to the Kidney Disease: Improving Global Outcomes guidelines 4

Produces microcytic anemia with low MCHC but distinguished by normal or low RDW (<14.0%), as stated by the American College of Medical Genetics and Genomics 1
Red cell count is usually elevated, unlike iron deficiency 2
Requires laboratory confirmation before presuming ethnicity-related hemoglobinopathy as the cause 2

Less commonly cause low MCHC than iron deficiency 1
C-reactive protein measurement helps identify inflammatory contribution 1
Ferritin acts as an acute-phase reactant and may be elevated despite true iron deficiency, as indicated by the National Institute of Diabetes and Digestive and Kidney Diseases 4

In patients with cyanotic heart disease, low MCHC indicates iron deficiency superimposed on polycythemia, creating a particularly dangerous situation, as stated by the American Heart Association 1
Iron-deficient microcytic hypochromic cells become rigid and less deformable in microcirculation 1
This combination significantly increases cardiovascular risk 1

Anemia in CKD is typically normochromic and normocytic, so low MCHC suggests additional iron deficiency, according to the Kidney Disease: Improving Global Outcomes guidelines 4
Low MCHC reflects left atrial overload and left ventricular hypertrophy in CKD patients, as indicated by the American Society of Nephrology 4

Do not attribute low MCHC to dietary insufficiency or menstruation without excluding gastrointestinal malignancy in appropriate populations, as recommended by the American College of Gastroenterology 2
Mild anemia is equally indicative of important disease as severe anemia 2
Combined deficiencies (e.g., iron plus folate) may mask microcytosis but show elevated red cell distribution width 2

Treatment of the underlying cause cures the anemia, as stated by the American College of Physicians 2
Even when no cause is detected after thorough investigation, long-term outlook remains good 2